Przegląd publikacji

Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study

Hua Tu, He Huang, Yi Ouyang, Qing Liu, Bingna Xian, Kun Song, Gang Chen, Yuanming Shen and Jihong Liu

Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer

Nicole D Fleming, Shannon N Westin, Larissa A Meyer, Aaron Shafer, Jose Alejandro Rauh-Hain, Michaela Onstad, Lauren Cobb, Michael Bevers, Bryan M Fellman, Jennifer Burzawa, Priya Bhosale, Behrouz Zand, Amir Jazaeri, Charles Levenback, Robert L Coleman, Pamela T Soliman, Anil K Sood

Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer

Lijie Cao, Hao Wen, Zheng Feng, Xiaotian Han, Jun Zhu, Xiaohua Wu

Clinical and ultrasound characteristics of vaginal lesions

Federica Pozzati, Francesca Moro, Martina Leombroni, Valentina Bertoldo, Nausica Trivellizzi, Floriana Mascilini, Giulia Bolomini, Francesca Ciccarone, Giorgia Garganese, Giovanni Scambia, Antonia Carla Testa

Utilization and outcomes of sentinel lymph node biopsy in patients with early stage vulvar cancer

Catherine E Hermann, Dimitrios Nasioudis, Spyridon A Mastroyannis, Nawar A Latif, Ashley F Haggerty, Robert L Giuntoli II, Lori Cory, Sarah H Kim, Mark A Morgan, Emily M Ko

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti, Christina Fotopoulou, Antonio Gonzalez Martin, Sigurd Lax, Domenica Lorusso, Christian Marth, Philippe Morice, Remi A Nout, Dearbhaile O'Donnell, Denis Querleu, Maria Rosaria Raspollini, Jalid Sehouli, Alina Sturdza, Alexandra Taylor, Anneke Westermann, Pauline Wimberger, Nicoletta Colombo, François Planchamp, Carien L Creutzberg

Spontaneous pneumothorax secondary to an endometrial stromal sarcoma

Giselle A Suero-Abreu, MD; Rahim H Wooley, MD; Aldo Barajas-Ochoa, MD; Constantinos Lovoulos, MD; Keith P Guevarra, DO

Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial

Prof Rodney P Rocconi, MD; Elizabeth A Grosen, MD; Prof Sharad A Ghamande, MD; John K Chan, MD; Minal A Barve, MD; Jonathan Oh, MD; Devansu Tewari, MD; Peter C Morris, MD; Erin E Stevens, MD; Justin N Bottsford-Miller, MD; Min Tang, PhD; Phylicia Aaron, PhD; Laura Stanbery, PhD; Staci Horvath, CCRA; Gladice Wallraven, CCRA; Ernest Bognar, BS; Luisa Manning, MD; John Nemunaitis, MD; David Shanahan, BS; Prof Brian M Slomovitz, MD; Prof Thomas J Herzog, MD; Prof Bradley J Monk, MD; Prof Robert L Coleman, MD

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial

Jin Won Youn, PhD; Soo-Young Hur, MD; Jung Won Woo, PhD; Yong-Man Kim, MD; Myong Cheol Lim, MD; Sang Yoon Park, MD; Sang Soo Seo, MD; Jae Hong No, MD; Byoung-Gie Kim, MD; Jae-Kwan Lee, MD; So Jin Shin, MD; Kyungun Kim, BS Marya F Chaney, PhD; Yoon-Jeong Choi, MS You Suk Suh, PhD; Jong Sup Park, MD; Prof Young Chul Sung, PhD;

Strona korzysta z plików cookies w celu realizacji usług i zgodnie z Polityką Plików Cookies.

Możesz określić warunki przechowywania lub dostępu do plików cookies w Twojej przeglądarce.